A single-center experience with undifferentiated embryonal sarcoma of the liver Academic Article uri icon

Overview

MeSH Major

  • Liver Neoplasms
  • Neoplasms, Germ Cell and Embryonal
  • Sarcoma

abstract

  • Undifferentiated embryonal sarcoma of the liver (UESL) is a rare aggressive mesenchymal pediatric tumor. Previously, reported outcomes have been very poor. Here, we report a single-center experience of five patients with UESL treated with upfront gross total resection and adjuvant chemotherapy. We have a median follow-up of 8 years with a range from 5 to 19 years with 100% event-free survival.

publication date

  • December 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5073002

Digital Object Identifier (DOI)

  • 10.1002/pbc.26154

PubMed ID

  • 27427850

Additional Document Info

start page

  • 2246

end page

  • 2248

volume

  • 63

number

  • 12